XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities    
Net income $ 288,869 $ 266,778
Adjustments to reconcile net income to net cash provided by operating activities:    
Gain (Loss) on Disposition of Property Plant Equipment (14,361) (460)
Depreciation and amortization 64,619 60,979
Noncash lease expense 14,789 11,902
Release of acquisition related tax and legal contingency 0 (1,830)
Loss in equity method investment, before tax 450 645
Deferred income taxes 3,549 (9,189)
Noncash compensation related to stock plans and other changes in the fair value of DCP 19,716 16,017
Provision for credit losses 1,772 70
Deferred hedge gain (5,320) (2,556)
Changes in operating assets and liabilities    
Trade accounts receivable (101,822) (73,474)
Inventories 20,819 (28,066)
Trade accounts payable 1,330 6,085
Other current assets 454 (7,848)
Accrued liabilities and other current liabilities 21,737 (3,648)
Other noncurrent assets and liabilities (13,629) (13,040)
Net cash provided by operating activities 302,972 222,365
Cash flows from investing activities    
Capital expenditures (124,343) (124,848)
Payments to Acquire Businesses, Net of Cash Acquired (77,641)
Purchases of equity investments (3,236) (1,495)
Proceeds from sale of property and equipment 21,050 1,869
Net cash used in investing activities (106,529) (202,115)
Cash flows from financing activities    
Repurchase of common stock (90,000) (50,000)
Issuance of common stock 3,526 0
Proceeds from line of credits 29,509 1,296
Repayments of line of credit and term loan (45,939) (20,080)
Dividends paid (35,557) (34,694)
Cash paid on behalf of employees for shares withheld (4,680) (7,554)
Net cash used in financing activities (143,141) (111,032)
Effect of exchange rate changes on cash and cash equivalents 4,631 387
Net decrease in cash and cash equivalents 57,933 (90,395)
Cash and cash equivalents at beginning of period 239,371 429,822
Cash and cash equivalents at end of period 297,304 339,427
Noncash activity during the period    
Noncash capital expenditures 8,010 6,294
Dividends declared but not paid 11,962 11,806
Issuance of Company’s common stock for compensation $ 3,526 $ 0